U.S. Stock News

NasdaqGS:AAON
NasdaqGS:AAONBuilding

AAON (AAON) Could Be 38% Undervalued On Raised BASX Revenue Outlook

AAON (AAON) drew fresh investor attention after management raised its 2026 revenue outlook for the BASX division to about US$1.0b from US$715m, citing stronger demand from AI focused data center projects. See our latest analysis for AAON. AAON's share price has been choppy around the AI data center story, with a 7 day share price return of 9.76% but a 90 day share price return that is down 27.93%, while the 5 year total shareholder return of 106.49% points to meaningfully stronger long term...
NasdaqGS:ENSG
NasdaqGS:ENSGHealthcare

Should Ensign Group’s (ENSG) Higher 2026 Earnings Guidance Prompt Action From Investors?

In late July 2026, The Ensign Group, Inc. reported past second-quarter 2026 results showing higher revenue and net income year over year, and the company raised its full-year 2026 earnings guidance to US$7.75–US$7.85 per diluted share on revenue of US$5.87–US$5.92 billion. An interesting takeaway is that the midpoint of Ensign’s updated earnings guidance implies very large growth over 2024 and solid improvement over 2025, underscoring management’s increased confidence in the business for...
NYSE:AGX
NYSE:AGXConstruction

Is Argan (AGX) Undervalued Following Its ValCor Acquisition Or Is Growth Priced In?

Argan (AGX) is back in focus after its subsidiary Southern Maryland Cable acquired Connecticut based ValCor Communications, extending the Teledata business into New England and adding customers across defense, aerospace, healthcare, banking, education, and technology. See our latest analysis for Argan. Against this acquisition backdrop, Argan’s share price has been volatile in recent months, with a 7 day share price return of 22.23% after a period where the 30 day share price return declined...
NasdaqGS:ERAS
NasdaqGS:ERASBiotechs

Do ERAS-0015 Lawsuits Hint at Deeper Pipeline Concentration Risks for Erasca (ERAS)?

In recent months, multiple law firms have launched class action investigations accusing Erasca of misleading investors about the safety, preclinical data, and intellectual property risks surrounding its lead oncology candidate ERAS-0015, following disclosures of a patient death, adverse clinical findings, and patent infringement claims. The concentration of legal scrutiny on ERAS-0015 underscores how alleged weaknesses in a single flagship asset’s safety and patent position can reshape...
NasdaqGS:LRCX
NasdaqGS:LRCXSemiconductor

Why Lam Research (LRCX) Is Up 21.8% After Strong Q4 Results And AI-Driven Margin Guidance

In late July 2026, Lam Research reported fourth-quarter sales of US$6,722.24 million and full-year sales of US$23,232.69 million, alongside issuing guidance for September 2026 revenue of about US$8.10 billion with a U.S. GAAP operating margin near 39.5% and diluted EPS around US$2.15. The results and guidance highlight how AI-driven semiconductor demand and expanded fab investment are supporting higher revenues, profitability and visibility for Lam’s equipment and services business. Next,...
NYSE:STWD
NYSE:STWDMortgage REITs

Starwood Property Trust (STWD) Trades Below Fair Value, Is It Still A Bargain?

How Starwood Property Trust Stock Has Been Performing Starwood Property Trust (STWD) has attracted attention after a period of weaker share performance, with the stock down about 3% over the past month and about 10% over the past 3 months. Over a longer horizon, the picture is mixed. Total return is down about 7% over the past year and down about 12% year to date, yet remains positive over the past 3 and 5 years. See our latest analysis for Starwood Property Trust. At a share price of $16.21,...
NasdaqGM:SITM
NasdaqGM:SITMSemiconductor

Is SiTime (SITM) Undervalued After Q2 Earnings And The Renesas Timing Deal?

Why SiTime’s latest earnings matter for investors SiTime (SITM) is back on investors’ radar after its second quarter 2026 results and the completion of its acquisition of Renesas' Timing Business, which together reshape the company’s scale and product lineup. For readers tracking semiconductor stocks, this combination of fresh financial data and a larger portfolio provides new information about how SiTime is positioned in timing solutions used in data centers, communications and other end...
NasdaqGM:XNCR
NasdaqGM:XNCRBiotechs

Does Xencor’s Mixed 2026 Loss Trend Reshape the Investment Narrative Around XNCR’s R&D Priorities?

Xencor, Inc. has reported its second-quarter and half-year 2026 results, with quarterly net loss narrowing to US$21.73 million and basic loss per share from continuing operations improving to US$0.29, while the six-month net loss widened to US$150.65 million and loss per share to US$1.99. This contrast between an improving second quarter and a much larger year-to-date loss highlights how shifts in spending and development activity are affecting Xencor’s financial profile. We’ll now examine...
NYSE:W
NYSE:WSpecialty Retail

Wayfair (W) Is Up 20.8% After Strongest Post-Pandemic U.S. Growth And Perigold Surge - Has The Bull Case Changed?

Wayfair reported past second-quarter 2026 results with sales of US$3.52 billion, up from US$3.27 billion a year earlier, while swinging from a US$15 million net profit to a small US$1 million net loss. The company’s strongest U.S. growth since the pandemic, driven by higher-income shoppers and over 35% growth at luxury brand Perigold, underpinned its best free cash flow since 2020 and ongoing expansion of physical stores. We’ll now examine how Wayfair’s strongest post-pandemic U.S. revenue...
NYSE:DLX
NYSE:DLXCommercial Services

Deluxe (DLX) Earnings Beat Puts Its Valuation Back In Focus

Deluxe (DLX) drew fresh attention after reporting second quarter 2026 earnings. Revenue reached US$499.3 million and net income was US$19.1 million, both slightly lower than a year earlier but ahead of analyst expectations. See our latest analysis for Deluxe. Deluxe shares trade at US$26.62 after a small pullback over the past week. However, the 30 day share price return of 10.27% and year to date share price return of 19.96% suggest momentum is still building, supported by a 1 year total...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

IDEAYA Biosciences (IDYA) Stock Could Be Fully Valued After Trial Progress

IDEAYA Biosciences stock has delivered a 61.0% return over the past five years, yet the current valuation checks and market multiples suggest investors are paying up for that performance rather than seeing an obvious bargain. A 61.0% five year return highlights that IDEAYA Biosciences has already rewarded patient shareholders, which can raise the bar for future returns at today’s price. Progress on IDEAYA Biosciences' oncology pipeline, including late stage and earlier stage programs, may...
NYSE:MUSA
NYSE:MUSASpecialty Retail

Murphy USA (MUSA) Stock Looks Expensive Following Its 295% Five Year Run

Murphy USA stock has delivered very strong returns over the past five years, yet both its Discounted Cash Flow (DCF) intrinsic value estimate and market based multiples currently indicate the shares trade at a premium. Murphy USA has returned 295.3% over the past five years, which puts extra focus on whether the current share price still reflects a reasonable long term cash flow outlook. Expectations for continued cash generation from its fuel and convenience retail network can support the...
NasdaqGS:PEP
NasdaqGS:PEPBeverage

PepsiCo (PEP) Stock Looks Reasonable Despite Low Carbon Supply Chain News

PepsiCo stock has delivered a decline of 16.2% over the past three years, yet current valuation checks suggest the shares may now be trading below an estimate of intrinsic value based on a Discounted Cash Flow (DCF) approach and earnings multiples. Over the last three years, PepsiCo has produced a decline of 16.2%, which raises the question of whether recent weakness has already priced in a lot of bad news. PepsiCo's work with suppliers on lower carbon inputs, such as the environmental...
NYSE:SMA
NYSE:SMASpecialized REITs

Is SmartStop Self Storage REIT (SMA) A Bargain As Earnings And Dividend News Lands?

Earnings and Dividend Actions Put SmartStop Self Storage REIT in Focus SmartStop Self Storage REIT (SMA) moved into the spotlight after its Board declared an August monthly dividend and the company reported second quarter and first half 2026 earnings results on August 5, 2026. See our latest analysis for SmartStop Self Storage REIT. The recent earnings release and dividend decision come as SmartStop Self Storage REIT trades at US$33.85, with a 1 month share price return of 3.20% and a year to...
NasdaqGM:SHLS
NasdaqGM:SHLSElectrical

Shoals Technologies Group (SHLS) Is Up 9.3% After Q2 Beat And TerraFlow Deal - Has The Bull Case Changed?

In early August 2026, Shoals Technologies Group reported second-quarter 2026 results showing sales rising to US$163.37 million from US$110.84 million a year earlier, while net income eased to US$12.14 million from US$13.86 million, and reaffirmed full-year 2026 revenue guidance of US$600 million to US$640 million alongside third-quarter guidance of US$150 million to US$170 million. At the same time, Shoals announced a Memorandum of Understanding with TerraFlow Energy to pair its PowerHub and...
NYSE:KMT
NYSE:KMTMachinery

Does Strong Q4 Earnings, 2027 Outlook and New Chair Change The Bull Case For Kennametal (KMT)?

Kennametal Inc. recently reported fourth-quarter 2026 results showing sales of US$736.61 million and net income of US$226.98 million, alongside issuing fiscal 2027 guidance that projects quarterly sales of US$745 million to US$775 million and full-year sales of US$3.33 billion to US$3.45 billion with neutral foreign exchange impact. The company also declared a US$0.20 quarterly dividend and announced Joseph Alvarado as incoming chairman, underscoring a combination of earnings strength,...
NasdaqGS:ORLY
NasdaqGS:ORLYSpecialty Retail

O'Reilly Automotive (ORLY) Could Be 15% Undervalued On Raised Full Year Guidance

Q2 earnings beat and guidance lift put O'Reilly Automotive in focus O'Reilly Automotive (ORLY) drew fresh attention after reporting Q2 2026 sales of US$4.89b, an 8.1% year on year increase, and raising its full year revenue outlook alongside firmer professional segment demand. See our latest analysis for O'Reilly Automotive. The latest Q2 beat and guidance lift come after a mixed stretch for O'Reilly Automotive investors, with a 10.9% 1 month share price return contrasting with a 10.5%...
NYSE:ESAB
NYSE:ESABMachinery

ESAB (ESAB) Posted Mixed Earnings, Is The Stock A Bargain?

ESAB earnings event and why it matters now ESAB (ESAB) reported second quarter and six month results to July 3, 2026, with higher sales and lower profitability year over year. Investors now have fresh data to reassess the stock. See our latest analysis for ESAB. ESAB shares have been under pressure over 2026, with the year to date share price return down 17.86% and the 90 day share price return down 9.69%. However, the 3 year total shareholder return of 30.98% shows a stronger longer term...
NYSE:MP
NYSE:MPMetals and Mining

MP Materials Stock Leads 3 High Growth Picks With Strong Balance Sheet Backing

German factory orders recently picked up, with processing equipment, electronics and automotive demand showing fresh momentum. That points to pockets of real growth even as global headlines stay mixed. For investors, this creates an opportunity to focus on companies where analysts already expect strong earnings growth and balance sheet strength. This article highlights three stocks from the Healthy high growth potential screener that fit that brief. The three stocks below are just a starting...
NasdaqCM:ESTA
NasdaqCM:ESTAMedical Equipment

Is Establishment Labs Holdings (ESTA) Undervalued After Its Earnings Beat And Raised Guidance?

Establishment Labs Holdings (ESTA) drew investor attention on 6 August 2026 after reporting second quarter results with higher sales, a smaller net loss than a year earlier, and raised full year revenue guidance. See our latest analysis for Establishment Labs Holdings. Despite the earnings beat and raised guidance on 6 August 2026, Establishment Labs Holdings shares closed at US$91.25 after a 1 day share price return that declined 3.55%. However, the 90 day share price return of 26.68% and 1...
NYSE:MAA
NYSE:MAAResidential REITs

Lower EPS Guidance And Buyback Completion Could Be A Game Changer For Mid-America Apartment Communities (MAA)

In late July 2026, Mid-America Apartment Communities reported second-quarter results with modest sales growth to US$555.13 million and higher quarterly net income, but weaker first-half earnings compared with a year earlier. On the same day, the company lowered its full-year 2026 diluted EPS guidance range to US$3.96–US$4.20 from US$4.18–US$4.50, while also completing a US$150 million buyback that retired 1% of its shares since 2015. Now we’ll examine how the reduced 2026 earnings guidance...
NYSE:UPS
NYSE:UPSLogistics

UPS Stock And 2 Logistics Plays Riding The West Coast Port Surge

A surge of cargo is racing through West Coast ports ahead of a July 2026 tariff deadline, and that rush is quietly reshaping where money moves in the market. Companies tied to this import wave could see very different fortunes from those left on the sidelines, which creates a window you may not want to miss. This article walks through 3 stocks exposed to this trade shock and how each could be affected. Expeditors International of Washington (EXPD) Overview: Expeditors International of...
NasdaqGS:RGLD
NasdaqGS:RGLDMetals and Mining

Why Royal Gold (RGLD) Is Up 10.0% After Surging H1 Earnings And Confident Metals Guidance

In the past quarter, Royal Gold, Inc. reported second-quarter 2026 sales of US$450.54 million and net income of US$236.39 million, with basic earnings per share from continuing operations rising to US$2.78. Over the first half of 2026, the company’s sales more than doubled to US$919.66 million and management issued full-year volume guidance across gold, silver, and copper, signaling confidence in its diversified metals portfolio. We’ll now examine how this sharp earnings growth and...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Did Profitability, Higher 2026 Guidance, and New Commercial Leadership Just Recast Arcutis Biotherapeutics' (ARQT) Investment Narrative?

Arcutis Biotherapeutics, Inc. recently reported that chief commercial officer L. Todd Edwards will resign in August 2026, while also posting second-quarter 2026 revenue of US$129.86 million and net income of US$15.01 million and raising full-year 2026 net product sales guidance to US$525 million–US$540 million. An interesting aspect is that Arcutis is turning profitable and lifting its outlook at the same time it brings in seasoned commercial leader Robert Lisicki, whose prior experience...